Related Experiment Video
Updated: May 11, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
New treatment guidelines for penile cancer
1Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida 33612, USA. philippe.spiess@moffitt.org
Summary
Penile cancer requires early treatment for better outcomes. This article highlights the National Comprehensive Cancer Network (NCCN) Guidelines for penile cancer management, including primary lesions and lymph nodes.
Area of Science:
- Oncology
- Urology
Background:
- Penile cancer is rare in Western countries but has high morbidity and mortality.
- Early medical or surgical intervention is crucial for favorable outcomes.
- Limited prospective data exist, leading to varied treatment approaches.
Purpose of the Study:
- To present key recommendations from the inaugural National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for penile cancer.
- To focus on treatment strategies for primary penile lesions and regional lymph nodes.
Main Methods:
- Review of the inaugural NCCN Clinical Practice Guidelines for penile cancer.
- Focus on treatment strategies for primary penile lesions and regional lymph nodes.
- Brief exploration of surveillance and management of recurrence and metastatic disease.
Main Results:
- Highlights NCCN recommendations for primary penile cancer treatment.
- Addresses management of regional lymph nodes.
- Includes surveillance and metastatic disease considerations.
Conclusions:
- The NCCN Guidelines provide a standardized approach to penile cancer care.
- Early diagnosis and treatment are emphasized for improved patient outcomes.
- Guidelines cover primary lesions, lymph nodes, surveillance, and advanced disease.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...